Shanghai Sanyou Medical Co., Ltd

SHSE:688085 Stock Report

Market Cap: CN¥4.8b

Shanghai Sanyou Medical Future Growth

Future criteria checks 5/6

Shanghai Sanyou Medical is forecast to grow earnings and revenue by 45.2% and 28.5% per annum respectively. EPS is expected to grow by 46.8% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

45.2%

Earnings growth rate

46.8%

EPS growth rate

Medical Equipment earnings growth25.7%
Revenue growth rate28.5%
Future return on equity7.4%
Analyst coverage

Low

Last updated02 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings Troubles May Signal Larger Issues for Shanghai Sanyou Medical (SHSE:688085) Shareholders

Nov 04
Earnings Troubles May Signal Larger Issues for Shanghai Sanyou Medical (SHSE:688085) Shareholders

Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) 26% Jump Shows Its Popularity With Investors

Oct 28
Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) 26% Jump Shows Its Popularity With Investors

Returns On Capital Signal Tricky Times Ahead For Shanghai Sanyou Medical (SHSE:688085)

Oct 01
Returns On Capital Signal Tricky Times Ahead For Shanghai Sanyou Medical (SHSE:688085)

Shanghai Sanyou Medical's (SHSE:688085) Soft Earnings Are Actually Better Than They Appear

May 02
Shanghai Sanyou Medical's (SHSE:688085) Soft Earnings Are Actually Better Than They Appear

Calculating The Fair Value Of Shanghai Sanyou Medical Co., Ltd (SHSE:688085)

Apr 16
Calculating The Fair Value Of Shanghai Sanyou Medical Co., Ltd (SHSE:688085)

Market Participants Recognise Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Earnings Pushing Shares 25% Higher

Mar 04
Market Participants Recognise Shanghai Sanyou Medical Co., Ltd's (SHSE:688085) Earnings Pushing Shares 25% Higher

Earnings and Revenue Growth Forecasts

SHSE:688085 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026880180N/A2372
12/31/2025700152N/A1082
12/31/2024559111N/A-22
9/30/20244343883106N/A
6/30/202439034111138N/A
3/31/202438659144178N/A
12/31/202346096241267N/A
9/30/2023527132161227N/A
6/30/202363517788194N/A
3/31/202368019260179N/A
12/31/202264919118156N/A
9/30/202265619855183N/A
6/30/202262919391200N/A
3/31/202260519070163N/A
12/31/202159318653145N/A
9/30/20215401522572N/A
6/30/20215011513467N/A
3/31/20214591373071N/A
12/31/20203901194778N/A
9/30/20203681053185N/A
6/30/202034486-1749N/A
3/31/202033290-2657N/A
12/31/201935498-1862N/A
12/31/201822262-4120N/A
12/31/20171405N/A22N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688085's forecast earnings growth (45.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 688085's earnings (45.2% per year) are forecast to grow faster than the CN market (25.5% per year).

High Growth Earnings: 688085's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688085's revenue (28.5% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 688085's revenue (28.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688085's Return on Equity is forecast to be low in 3 years time (7.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 09:17
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Sanyou Medical Co., Ltd is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wei SunChina Merchants Securities Co. Ltd.
Yuan Yuan SunIndustrial Securities Co. Ltd.
Jiaqi ZhuZhongtai Securities Co. Ltd.